NCCN would like to thank the outstanding faculty who are presenting and all of you for attending this educational event. We hope you find the information presented useful to your practice, and we encourage you to attend future NCCN educational initiatives.  

To download PDF handouts of the slides, please click the links below:

• Program Overview (agenda, accreditation information, disclosure information, and faculty biographies)
• General Principles of Biomarker Testing: When Should Broad Genomic Profiling Be Performed and What Do Different Tests Offer? (Jennifer J. D. Morrissette, PhD)
• General Principles of Test Interpretations: What Results are Actionable and How to Advise Patients About Results? (Dara L. Aisner, MD, PhD)
• Clinical Scenario #1: Applying Biomarkers in Metastatic Non-Small Cell Lung Cancer (Jonathan E. Dowell, MD; Jeffrey Gagan, MD, PhD)
• Clinical Scenario #2: Applying Biomarkers in Metastatic Breast Cancer (Kimberly H. Allison, MD; Melinda L. Telli, MD)
• Clinical Scenario #3: Applying Biomarkers in Melanoma (Donald A. Baldwin, PhD; Anthony J. Olszanski, MD, RPh)
• Clinical Scenario #4: Evolving Applications of PARP Inhibitors in Various Cancers (Dana Farengo-Clark, MS, LCGC; Susan M. Domchek, MD)
• Clinical Scenario #5: Applying Biomarkers in Colorectal Cancer (Terri L. Blase, MS, CGC; Kelsey A. Klute, MD; Benjamin J. Swanson, MD, PhD)
• What’s on the Horizon? (Jennifer J. D. Morrissette, PhD; Aparna R. Parikh, MD, MS; David T. Ting, MD)